Scleroderma--developing measures of response
Furst, D.E.; Khanna, D.; Mattucci-Cerinic, M.; Silman, A.J.; Merkel, P.A.; Foeldvari, I.
Journal of Rheumatology 32(12): 2477-2480
2005
ISSN/ISBN: 0315-162X PMID: 16331791 Document Number: 591455
The scleroderma research community continued its focus on the development and proper validation of the outcome measures for clinical trials in scleroderma during the special interest group meeting at OMERACT 7. Deliberations focused on progress in the assessment of gastrointestinal disease, renal physiology, vascular damage, and the unique challenges inherent in studying pediatric patients with scleroderma.